Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Karyopharm Therapeut

(NASDAQ: KPTI)
Add to Portfolio
+0.08 (+0.52%)
as of 13:29 EST

Last 15.52
Change +0.08 (+0.52%)
Open 15.54
Prev. Close 15.44
Today's Range
15.30
15.75
52wk Range
3.92
15.80
Volume 421,582
Avg Volume 1,442,219
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
KPTI +0.52% +50.34% +45.04%
DJIA -0.35% +3.85% +11.63%
S&P 500 -0.03% +4.78% +15.93%

Key Statistics

Annual EPS -3.43
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 964,140
Weighted Alpha +104.69
Standard Deviation +0.13
Profit Margin N/A
Beta 2.43

Growth Rates

YTD +65.42%
1-Year +46.91%
3-Year +55.80%
5-Year -63.13%

Opinion

Sell Hold Buy

Recent Headlines

Karyopharm Thera Set to Possibly Pullback After

Comtex SmarTrend(R) via COMTEX - Mon Nov 11, 12:40PM EST
Karyopharm Thera (NASDAQ:KPTI) traded in a range yesterday that spanned from a low of $14.60 to a high of $15.07. Yesterday, the shares gained 48.0%, which took the trading range above the 3-day high of $14.96 on volume of 288,0(full story)
KPTI: 15.52 (+0.08)

Watch for Karyopharm Thera to Potentially Pullback

Comtex SmarTrend(R) via COMTEX - Wed Nov 06, 12:36PM EST
Karyopharm Thera (NASDAQ:KPTI) traded in a range yesterday that spanned from a low of $14.15 to a high of $14.69. Yesterday, the shares gained 42.8%, which took the trading range above the 3-day high of $14.56 on volume of 745,0(full story)
KPTI: 15.52 (+0.08)

Karyopharm Announces XPOVIO(R) (Selinexor) Clinical

GlobeNewswire via COMTEX - Wed Nov 06, 10:12AM EST
-- Updated Results from the Pomalyst(R) and Kyprolis(R) Arms of the Phase 1b/2 STOMP Study Evaluating Selinexor in Combination with Other Approved Myeloma Therapies in Relapsed or Refractory Multiple Myeloma to be Highlighted --(full story)
KPTI: 15.52 (+0.08)

Karyopharm Thera has the Best Relative Performance in

Comtex SmarTrend(R) via COMTEX - Tue Nov 05, 03:27AM EST
Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming. This is what we found:(full story)
IRWD: 11.81 (+0.36), KPTI: 15.52 (+0.08), SRPT: 97.89 (-0.01)

Karyopharm Reports Third Quarter 2019 Financial

GlobeNewswire via COMTEX - Mon Nov 04, 07:00AM EST
â?' XPOVIO Phase 2b STORM Study Results Published in The New England Journal of Medicine â?'(full story)
KPTI: 15.52 (+0.08)